Abstract:BackgroundSeveral epidemiological studies have suggested that vitamin D status is associated with risk of dementia in general populations. However, due to the synergistic effect between diabetic pathology and neuroinflammation, and the prothrombotic profile in patients with diabetes, whether vitamin D is associated with risk of dementia among patients with diabetes is unclear. This study aimed to investigate the associations of circulating vitamin D levels with risks of all-cause dementia, Alzheimer disease (AD), and vascular dementia (VD) among adults with type 2 diabetes (T2D).Methods and findingsThis study included 13,486 individuals (≥60 years) with T2D and free of dementia at recruitment (2006-2010) from the UK Biobank study. Serum 25-hydroxyvitamin D (25[OH]D) concentrations were measured using the chemiluminescent immunoassay method at recruitment. Serum 25(OH)D ≥ 75 nmol/L was considered sufficient, according to the Endocrine Society Clinical Practice Guidelines. Incidence of all-cause dementia, AD, and VD cases was ascertained using electronic health records (EHRs). Each participant's person-years at risk were calculated from the date of recruitment to the date that dementia was reported, date of death, date of loss to follow-up, or 28 February 2018, whichever occurred first. Among the 13,486 individuals with T2D (mean age, 64.6 years; men, 64.3%), 38.3% had vitamin D ≥ 50 nmol/L and only 9.1% had vitamin D ≥ 75 nmol/L. During a mean follow-up of 8.5 years, we observed 283 cases of all-cause dementia, including 101 AD and 97 VD cases. Restricted cubic spline analysis demonstrated a nonlinear relationship between serum 25(OH)D and risk of all-cause dementia (Pnonlinearity < 0.001) and VD (Pnonlinearity = 0.007), and the nonlinear association reached borderline significance for AD (Pnonlinearity = 0.06), with a threshold at around a serum 25(OH)D value of 50 nmol/L for all the outcomes. Higher serum levels of 25(OH)D were significantly associated with a lower risk of all-cause dementia, AD, and VD. The multivariate hazard ratios and 95% confidence intervals for participants who had serum 25(OH)D ≥ 50 nmol/L, compared with those who were severely deficient (25[OH]D < 25 nmol/L), were 0.41 (0.29-0.60) for all-cause dementia (Ptrend < 0.001), 0.50 (0.27-0.92) for AD (Ptrend = 0.06), and 0.41 (0.22-0.77) for VD (Ptrend = 0.01). The main limitation of the current analysis was the potential underreporting of dementia cases, as the cases were identified via EHRs.ConclusionsIn this study, we observed that higher concentrations of serum 25(OH)D were significantly associated with a lower risk of all-cause dementia, AD, and VD among individuals with T2D. Our findings, if confirmed by replication, may have relevance for dementia prevention strategies that target improving or maintaining serum vitamin D concentrations among patients with T2D.

Vitamin D Concentration and Risk of Alzheimer Disease: A Meta-Analysis of Prospective Cohort Studies.

Vitamin D deficiency as a risk factor for dementia and Alzheimer’s disease: an updated meta-analysis

Association of Vitamin D Levels with Risk of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Prospective Studies

Vitamin D Levels in Alzheimer’s and Parkinson’s Diseases: A Meta-Analysis

Serum 25-Hydroxyvitamin D in Relation to Disability in Activities of Daily Living, Mobility, and Objective Physical Functioning among Chinese Older Adults.

The associations of serum vitamin D status and vitamin D supplements use with all-cause dementia, Alzheimer’s disease, and vascular dementia: a UK Biobank based prospective cohort study

Dietary Fat Intake and Risk of Alzheimer's Disease and Dementia: A Meta-Analysis of Cohort Studies.

Association Between Serum Vitamins and the Risk of Alzheimer's Disease in Chinese Population

Impact of Vitamin D Binding Protein Levels on Alzheimer's Disease: A Mendelian Randomization Study.

Association of Serum Vitamin C Concentrations with Alzheimer’s Disease Mortality among U.S. Adults

Vitamin D, Cognition, and Alzheimer's Disease: Observational and Two-Sample Mendelian Randomization Studies

Circulating vitamin E levels and Alzheimer's disease: a Mendelian randomization study.

Association of Serum 25-Hydroxyvitamin D Concentrations with Risk of Dementia among Individuals with Type 2 Diabetes: A Cohort Study in the UK Biobank

The Relation of Serum Vitamin C Concentrations with Alzheimer's Disease Mortality in a National Cohort of Community-Dwelling Elderly Adults

The Impact of Plasma Vitamin C Levels on the Risk of Cardiovascular Diseases and Alzheimer's Disease: A Mendelian Randomization Study.

Serum Uric Acid Levels in Patients with Alzheimer's Disease: A Meta-Analysis

Association of serum vitamin C concentrations with Alzheimer's disease mortality among U.S. adults

The Moderating Effect of Serum Vitamin D on the Relationship between Beta-amyloid Deposition and Neurodegeneration

Effects of vitamin D 3 supplementation on cognition and blood lipids: a 12-month randomised, double-blind, placebo-controlled trial.

The Association between Vitamin D Deficiency and Changes in Cognitive Functions in Chinese Older Adults: A Prospective Cohort Study

The Role of Vitamin D as a Biomarker in Alzheimer's Disease